New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays
Open accessThe DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index; 9 of the 54 sources its claims cite were checked for support.
Abstract
Context: The normal cortisol response 30 or 60 minutes after cosyntropin (ACTH[1–24]) is considered to be ≥18 μg/dL (500 nmol/L). This threshold is based on older serum cortisol assays. Specific monoclonal antibody immunoassays or LC-MS/MS may have lower thresholds for a normal response. Objective: To calculate serum cortisol cutoff values for adrenocorticotropic hormone (ACTH) stimulation testing with newer specific cortisol assays. Methods: Retrospective analysis of ACTH stimulation tests performed in ambulatory and hospitalized patients suspected of adrenal insufficiency (AI). Serum samples were assayed for cortisol in parallel using Elecsys I and Elecsys II immunoassays, and when volume was available, by Access immunoassay and LC-MS/MS. Results: A total of 110 patients were evaluated. Using 18 μg/dL as the cortisol cutoff after ACTH stimulation, 14.5%, 29%, 22.4%, and 32% of patients had a biochemical diagnosis of AI using the Elecsys I, Elecsys II, Access, and LC-MS/MS assays, respectively. Deming regressions of serum cortisol were used to calculate new cortisol cutoffs based on the Elecsys I cutoff of 18 μg/dL. For 30-minute values, new cutoffs were 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS. Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values. Conclusion: To reduce false positive ACTH stimulation testing, we recommend a new serum cortisol cutoff of 14 to 15 μg/dL depending on the assay used (instead of the historical value of 18 μg/dL with older polyclonal antibody assays). Clinicians should be aware of the new cutoffs for the assays available to them when evaluating patients for AI.
Overview
CoChat Summary
TL;DR
In 110 patients suspected of adrenal insufficiency, newer specific cortisol assays gave lower ACTH-stimulated cortisol values than the older Elecsys I polyclonal assay, so the historical 18 μg/dL cutoff produced more biochemical AI diagnoses. The authors recommend assay-specific post-cosyntropin cutoffs of 14 to 15 μg/dL to reduce false-positive ACTH stimulation tests.
Key findings
- Using the historical 18 μg/dL cutoff, biochemical AI was diagnosed in 14.5% with Elecsys I, 29% with Elecsys II, 22.4% with Access, and 32% with LC-MS/MS.
- Deming regression from the Elecsys I 18 μg/dL cutoff yielded 30-minute cutoffs of 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS; 60-minute cutoffs were 14.7, 14.5, and 13.7 μg/dL, respectively.
- Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values, while values between 2 and 8 μg/dL overlapped substantially between normal and subnormal responders.
- Discordant CST results occurred in 8 of 110 patients (7.3%) across assays using new cutoffs; most abnormal values were close to the cutoff, and clinical review identified secondary AI in 3 of these 8.
Methods
- Retrospective analysis of residual serum samples from 110 ambulatory and hospitalized patients undergoing cosyntropin stimulation testing for suspected adrenal insufficiency from January 8, 2017 to April 30, 2017.
- Cosyntropin (250 mcg ACTH[1–24]) was given intravenously, with serum cortisol measured before injection and at 30 minutes; 60-minute samples were analyzed when ordered. Samples were run in parallel on Elecsys I and Elecsys II, and when volume allowed, on Beckman Access and LC-MS/MS.
- Deming regression was used to calculate new cutoffs from Elecsys I, with Bland-Altman bias analysis, ROC analysis, repeated-measures ANOVA, Mann-Whitney, and chi-square tests.
Limitations
- The paper states there was no independent endocrine test to determine whether patients truly had AI, and many patients lacked long-term follow-up to confirm chronic AI or sustained glucocorticoid need.
- The paper states the cohort came from diverse clinical settings and did not include a healthy subject cohort, though prior healthy-subject studies using specific assays found similar lower thresholds.
- The paper notes CST interpretation is limited without pre-test probability and may be affected by serum protein levels, concurrent medications, and proper timely execution; evident from the text, this was a retrospective single-protocol study using residual samples, with some assays having smaller sample numbers because of insufficient serum volume.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
5 Valid · 3 Not valid · 16 Not checked · 62 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Newer, more-specific cortisol assays with lower cross-reactivity to other endogenous steroids have replaced older, less-specific assays [8, 13, 15, 26, 27].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Not checked — no full text of the sourcecites [8] Kline GA, Buse J, Krause RD. Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem. 2017; 50(9): 475- 480. 28192125 source
- Not checked — no full text of the sourcecites [13] Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay. Ann Endocrinol (Paris). 2016; 77(5): 620- 622. 27449530 source
- Disputedcites [15] Vogeser M, Kratzsch J, Ju Bae Y, et al. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med. 2017; 55(6): 826- 835. 27898397 sourceExperimental — accuracy not yet measured
The Introduction (p. 2) says the second-generation assay was developed to improve specificity. But Table 2 (p. 4) reports greater cross-reactivity with cortisone, an endogenous steroid, for Cortisol II than for the first-generation assay (6.58% versus 0.30%). The paper also describes development and comparison of the two assays, not a general replacement of older assays. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [26] Ueland GA, Methlie P, Oksnes M, et al. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696-1703. 29452421 source
- Not checked — no full text of the sourcecites [27] El-Farhan N, Pickett A, Ducroq D, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf). 2013; 78(5): 673- 680. 22994849 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Serum cortisol concentrations are approximately 20% lower with the newer assays compared with the older assays in some studies [8, 13, 15, 26, 27].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Abstract > Conclusion
What the sources say
- Not checked — no full text of the sourcecites [8] Kline GA, Buse J, Krause RD. Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem. 2017; 50(9): 475- 480. 28192125 source
- Not checked — no full text of the sourcecites [13] Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay. Ann Endocrinol (Paris). 2016; 77(5): 620- 622. 27449530 source
- Supportedcites [15] Vogeser M, Kratzsch J, Ju Bae Y, et al. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med. 2017; 55(6): 826- 835. 27898397 source
The Method comparisons section (p. 5) reports that, for 541 serum samples, the second-generation Cortisol II assay had a slope of 0.76 and an intercept of 10.3 nmol/L relative to the first-generation assay. Those results support approximately 20% lower readings with the newer assay, though the percentage difference varies with concentration. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] Ueland GA, Methlie P, Oksnes M, et al. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696-1703. 29452421 source
- Not checked — no full text of the sourcecites [27] El-Farhan N, Pickett A, Ducroq D, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf). 2013; 78(5): 673- 680. 22994849 source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Grassi et al also found lower cortisol cutoff values of 12.7 and 13.3 μg/dL using Elecsys II and LC-MS/MS assays, respectively [37].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Supportedcites [37] Grassi G, Morelli V, Ceriotti F, et al. Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones (Athens). 2020; 19(3): 425- 431. 32222957 PMC7426310 source
The Discussion reports that the 500 nmol/L threshold corresponded to 351 nmol/L (12.7 μg/dL) with R2 and 368 nmol/L (13.3 μg/dL) with LC-MS/MS. The Assays section identifies R2 as Elecsys Cortisol II, matching the assays and values in the claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Discussion
What the sources say
- Not checked — no full text of the sourcecites [26] Ueland GA, Methlie P, Oksnes M, et al. The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696-1703. 29452421 source
- Not checked — no full text of the sourcecites [28] Burt MG, Mangelsdorf BL, Rogers A, et al. Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH1–24 stimulation in the assessment of pituitary patients. J Clin Endocrinol Metab. 2013; 98(5): 1883- 1890. 23539724 source
- Could not verifycites [38] Beuschlein F, Fassnacht M, Assié G, et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. N Engl J Med. 2014; 370(11): 1019- 1028. 24571724 PMC4727447 sourceExperimental — accuracy not yet measured
The Methods section on study patients describes biochemical criteria for corticotropin-independent Cushing’s syndrome, not an ACTH stimulation test comparing cortisol at 30 and 60 minutes. Searches for the quoted comparison and for ACTH stimulation with 30- and 60-minute cortisol assays found no passage addressing it in our copy. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On chart review, 3 of these 8 patients were clinically thought to have secondary AI.”
§ New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays > Results
plainn = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The proposed cutoffs may be applicable to other LC-MS/MS methods after validation but may differ for immunoassays (43, 44).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“The current diagnostic strategy for adrenal insufficiency is for patients to be referred for an ACTH stimulation test, using a cutoff to confirm (<15.6 mg/dl [430 nmol/l]) or exclude (15.6 mg/dl [430 nmol/l]) adrenal insufficiency.”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [26]
In the citing paper
“In the current study, adrenal insufficiency was defined as a peak cortisol level of <15.6 mg/dl (<430 nmol/l) measured by immunoassay.”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [26]
In the citing paper
“The new tools available to detect cortisol are the immunoassays utilizing monoclonal antibodies, such as Elecsys Cortisol generation II and Beckman Access Cortisol, and the Liquid chromatography–tandem mass spectrometry (LC-MS/MS), which is a non-antibody structural assay highly specific for cortisol [41,42,43,44].”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [44]
In the citing paper
“Over the last years, newer-generation assays with greater specificity for cortisol have been developed and have replaced the old assays in almost all the centers.”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [44]
Citations
Cites
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · cited 3×
“Patients with primary AI always have an elevated plasma ACTH, so CST is typically not needed for confirmation of the diagnosis [5, 6].”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737 · cited 2×
“As with any endocrine test, no absolute cortisol cutoff for the ACTH stimulation test is perfect for the diagnosis of AI [4, 7, 11, 12].”
BackgroundCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310359 · Cited by 443 · cited 1×
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442 · cited 6×
“Historically, immunoassays using polyclonal antibodies have been used to establish post-cosyntropin cortisol cutoff concentrations as high as 20 μg/dL [11, 12].”
BackgroundMethodInfluentialHusebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · cited 1×
“Patients with primary AI always have an elevated plasma ACTH, so CST is typically not needed for confirmation of the diagnosis [5, 6].”
BackgroundValue of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233 · cited 2×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodRapid adrenocorticotropic hormone test in practice. Retrospective review
May, M. E., & Carey, R. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90517-0 · Cited by 174 · cited 3×
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodThe approach to the adult with newly diagnosed adrenal insufficiency
Arlt, W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0032 · Cited by 165 · cited 1×
“Historically, a cortisol level at 30 or 60 minutes of >18 μg/ dL has been considered normal [5, 9, 10, 35, 36].”
Background
Cited by
Items 101–171 of 171
Symonds, C. J., Leung, A. A. C., & Kline, G. A. (2026) · Clinical Endocrinology · doi:10.1111/cen.70102 · Cited by 2
Langford, R., Lee, H. J., & Depczynski, B. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100151 · Cited by 2
Fukushima, K., Kitayama, S., Sazuka, M., Kodera, R., Oba, K., Toyoshima, K., Chiba, Y., Yamamoto, H., Araki, A., & Tamura, Y. (2024) · Cureus · doi:10.7759/cureus.60850 · Cited by 2
“The corticotropin-releasing hormone (CRH) loading test on day 157 showed a low response of both ACTH and cortisol ( The ACTH loading test on day 158 revealed a low cortisol response with a peak cortisol level of less than 14 μ g/ml (Table 3 ) [8].”
Backgroundde Oliveira, J. M., Genari, C. M., Sobral, P. M. S., Kater, C. E., & Costa‐Barbosa, F. A. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae100 · Cited by 2
Safely Withdrawing Glucocorticoid Therapy: A Case-Based Approach
Alenazi, M., Aldahmani, K. M., & Imran, S. A. (2024) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0044-1788035 · Cited by 2
“…test is typically de fi ned as more than 500nmol/L, but depending on the assay, some studies have suggested a cutoff of more than 386nmol/L. 34,38,39 Notably, many patients who may initially fail to show signs of HPA recovery still recover after several years, 40 so ongoing testing is…”
Carson, J. P., & Gronowski, A. M. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab136 · Cited by 2
Thulaseedharan, A., Jabbar, P. K., Nair, S., Chellamma, J., Rema, S. P. P., Das, D., Gomez, R., Sethuraman, S., Soumya, S., & Nair, A. (2025) · Clinical Endocrinology · doi:10.1111/cen.15282 · Cited by 1
Nervo, A., Gruosso, G., Marino, M., Migliore, E., Rubiolo, M., Vaccaro, E., & Arvat, E. (2025) · Clinical Endocrinology · doi:10.1111/cen.70023 · Cited by 1
“Recently, several studies have tried to identify assay ‐ specific cut ‐ offs to ensure a more accurate interpretation of SC [13, 14].”
Hataya, Y., Kurata, M., Murabe, K., Hakata, T., Fujimoto, K., Iwakura, T., Yamasaki, T., & Matsuoka, N. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02072-2 · Cited by 1
“However, more sensitive cortisol assays have been introduced, and a lower cutoff of approximately 15 μg/dL has been proposed for the diagnosis of PAI [14].”
Okutan, S., Borresen, S. W., Hilsted, L. M., Feldt‐Rasmussen, U., & Klose, M. (2025) · Pituitary · doi:10.1007/s11102-025-01608-y · Cited by 1
“The finding of lower cortisol concentrations and cut-off limits with the second-generation assay compared to the first-generation assay was consistent with earlier research in this field [ 6, 7, 11–13 ].”
Gasco, V., Bioletto, F., Lucisano, D., Camoirano, D., Cuboni, D., Varaldo, E., Sibilla, M., Aversa, L. S., Mocellini, F., Berton, A. M., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02807-5 · Cited by 1
“…regard, in recent years, studies have evaluated various second-generation cortisol immunoassays employing more specific antibod - ies and have proposed lower cortisol cut-off values for the ACTH test, ranging from 127 to 167 µg/L [25–31], which are below the previously recommended threshold [12].”
Watson, S. C., Garg, P. M., & Constantacos, C. (2026) · Journal of Perinatology · doi:10.1038/s41372-026-02592-2 · Cited by 1
Cortisol assays across the physiologic spectrum: access immunoassay compared with LC-MS/MS
Newman, A. J., Mahrokhian, S., Hanna, I., Tsai, C., Salle, S. P., Brown, J. M., Stouffer, D. G., Auchus, R. J., & Vaidya, A. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag043 · Cited by 2
Eisa, N. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-271276 · Cited by 1
“9 However, in this case, the cortisol response was unequivocally absent regardless of the specific assay threshold applied, confirming the diagnosis of central AI.”
Effraimidis, G., Kasotas, A., & Bargiota, Α. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag077 · Cited by 1
The utility of a random cortisol level in determining neonatal central adrenal insufficiency
Bulan, A., Pyle‐Eilola, A. L., Mamilly, L., Chaudhari, M., & Henry, R. K. (2023) · Clinical Endocrinology · doi:10.1111/cen.14903 · Cited by 2
“We also direct the practicing clinician to be aware of the specific cutoff for the cortisol methodology used by his/her institution, since assays have varying performance characteristics.(11) Further studies are needed to better define normal patterns of cortisol secretion and validate the performance of rSC levels in…”
BackgroundMethodMenon, L., Edem, D., Maradana, J., Sharma, P., & Tamhane, S. U. (2023) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0093 · Cited by 1
“This was considered an adequate response given the lower cutoff for newer cortisol assays (5).”
BackgroundAndrysiak-Mamos, E., Sagan, K. P., Zwarzany, Ł., Poncyljusz, W., & Syrenicz, A. (2023) · Endokrynologia Polska · doi:10.5603/ep.98271 · Cited by 1
Araya, A. V., Pineda, P., Cordero, F., Ávila, D., & González, J. (2025) · Revista médica de Chile · doi:10.4067/s0034-98872025000300162 · Cited by 1
Jialal, I., & Sood, A. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab112 · Cited by 1
“Dear Sir, We read with great interest the recent article in the Journal of the Endocrine Society by Javorsky et al [1] in which they suggest, based on their analysis of the adrenocorticotropin (ACTH) stimulation test on 110 patients, that the serum cortisol cutoffs for diagnosis of adrenal insufficiency be reduced to…”
MethodInfluentialJavorsky, B. R., Raff, H., Carroll, T. B., Algeciras‐Schimnich, A., Singh, R., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab113 · Cited by 1
Self-citationAdrenal insufficiency: a commentary
Ryan, A., & Twomey, P. J. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2022-208162
Clinical investigation of a unique type of hypothalamic adrenal insufficiency
Takeshita, K., Abe, I., Nagata, M., Ochi, K., Senda, Y., Koga, M., Ohe, K., Abe, M., Kudo, T., & Kobayashi, K. (2022) · Medicine · doi:10.1097/md.0000000000030597 · Cited by 1
“[19] Therefore, these could be a characteristic feature of ihAI.”
BackgroundInfluentialManosroi, W., & Atthakomol, P. (2023) · Medicina · doi:10.3390/medicina59010152 · Cited by 1
“AI was defined as either morning serum cortisol < 3 μg/dL or peak serum cortisol after a low-dose ACTH stimulation test of <15 μg/dL [16].”
BackgroundAnalysis of Cortisol Thresholds Using Newer Assays for Adrenocorticotropic Hormone Testing
Lutz, N., Beauregard, S., Newbern, D., Wilson, R., Shaibi, G. Q., Barger, K., Oatman, O. J., Touger, L., Velasquez, A., & KAPADIA, C. R. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104656
Hypopituitarism in Adults: Rational Approaches to Diagnosis and Treatment
Almalki, M. (2023) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0043-1768587
Barth, J. H. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0517
Law, C. C. Y., Peraza, J., Viera, N., Ungaro, R. C., Cheesman, K. C., Colombel, J., & Livanos, A. E. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08123-9
“A cortisol level 14–15 μg/dL depending on the assay used is considered diagnostic [5].”
MethodDynamic Tests in Clinical Endocrinology
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch9
Margolis, M. G., Lilos, P., Phillip, M., & de Vries, L. (2023) · Hormone Research in Paediatrics · doi:10.1159/000535779 · Cited by 2
Investigação de potenciais biomarcadores no diagnóstico da insuficiência adrenal central
Bitencourt, M. R. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-25042024-153831
Occult Adrenal Insufficiency in Patients with Chronic Renal Disease
El-Reshaid, K., Al-Bader, A., & Sallam, H. T. (2024) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2024.158023
Bhardwaj, S., Jaiswal, A. K., Yadav, S. C., Gupta, D., Yadav, R. R., Singh, A. P., & Bhatia, E. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_79_24
“[3,20] In patient with levels between 140 and 350 nmol/l, ACTH stimulation test was done to rule out cortisol deficiency (post‑actom cortisol >400 nmol/l).”
BackgroundMethodInfluentialImpact of sweet drink on pituitary response and subject comfort during insulin tolerance test
Carton, T., Thiry, C., Wolff, F., Corvilain, B., & Burniat, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-81401-2
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5833-1
Diagnostic Utility of Low-Dose Cosyntropin Stimulation Test for Central Adrenal Insufficiency
Morgante, C., Krishna, K. B., McCann, E., Witchel, S. F., Chemaitilly, W., Garibaldi, L., & Tas, E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543394
“A sub-analysis, using a lower cortisol cutoff of 16 μ g/dL (441 nmol/L), as suggested for this assay [10, 16], did not change the sensitivity and speci fi city of the cutoff values for the LDT in our study (data not shown).”
InfluentialVibhatavata, P., Santiwanit, K., & Charatcharoenwitthaya, N. (2025) · Asian Medical Journal and Alternative Medicine · doi:10.70933/2773-9465.1002
Almazrouei, R. A., Alshamsi, J., Abdelsalhen, M., Alkaabi, F., & Agha, A. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251335180
“Using the previously published cutoff for SST at 30 min with cutoffs ⩾ 408 nmol/L for Beckman-Access and ⩾ 402 nmol/L for Roche-Cobas Generation-II assays, 7–9 to define preserved adrenal function.”
Suspected Adrenocortical Deficiency
Vaidya, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-86099-7_17
Nolan, J. D., Brown, S. J., Henley, D., & Lim, E. M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf424 · Cited by 1
Evaluating Treatment Response, Biomarkers, and Outcome Reliability in Duchenne Muscular Dystrophy
Tobin, R. A. (2025) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2025-16562
Adriaansen, B. P. H., Utari, A., Olthaar, A. J., van der Steen, R. C. B. M., Pijnenburg-Kleizen, K. J., Berkenbosch, L., Span, P. N., Sweep, F. C. G. J., der Grinten, H. L. C., & van Herwaarden, A. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf451
Fernández-Velasco, P., Miralles, I. A., Lanchas, S. R., Torres, B., Buigues, A. O., Hoyos, E. G., Trapiello, W., Nieves, D. C., de Luis, D. A., & Díaz-Soto, G. (2025) · Endocrine · doi:10.1007/s12020-025-04455-w
Relative Nebenniereninsuffizienz
Maschmeier, M., & Heinzow, H. S. (2025) · Springer eBooks · doi:10.1007/978-3-662-70167-6_23
Iyer, P. C., Kikani, N. J., Khan, S., Chaudhri, A., Pagnotti, G. M., Best, C. J., Weitzman, S., Mehta, P. P., Lavis, V. R., Thosani, S., et al. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2593621
“The failure of cortisol to respond to ACTH stimulation to a level of ≥18 μg/dL (or 14–16 μg/dL if the level of cortisol is measured using newer, sensitive immunoassays) suggests AI [45,47].”
Adrenal Insufficiency: Diagnostic Approaches, Treatments, and Outcomes Volume II
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7003-6
Opioid-induced Endocrinopathies - A Narrative Review
Khalil, A., & Kalhan, A. (2025) · Academic Medicine & Surgery · doi:10.62186/001c.147430
Kronik Karaciğer Hastalıklarının Sistemik Bulguları
Önem, S., & Akarsu, M. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3785.c415
Adrenal insufficiency presenting with psychosis
Mantha, S., Modi, S., Lalwani, S., & Shekhawat, V. S. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-268064
Alteraciones endocrinometabólicas de pacientes con hiperferritinemia: estudio de un solo centro
Gómez, N. B., Jiménez-Salazar, S., Aguilar-Londoño, C., Ramos, A. F. G., Betancur, S. S., & Torres-Grajales, J. L. (2025) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.12.4.886
Инциденталома гипофиза: что надо знать?
Мохорт, Т. В. (2025) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2025.15.4.051
Adrenal Insufficiency in Adults
Abraham, S. B. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.12.001
Shrestha, E., Albert, S. G., Ghimire, A., Canales, S. P., Iqbal, I., & Akande, R. O. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.03.001
Dayno, A. N., Kilberg, M. J., Gonter, E., Gallop, R., Squicciarini, J., Montaño, C., & Vogiatzi, M. G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1745992
Abouzaglo, S., Herrington, G., Hamidi, O., Chapa, E., Helm, C., & Sutaria, J. M. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.03.008
Das, B., Fatima, T., & Sheikh, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-12937-6_14
Kato, S., Akanuma, H., Nara, M., Sato, T., Morii, T., Fujita, H., & Waki, H. (2026) · Cureus · doi:10.7759/cureus.107059
Tosun, B. G., Gacemer, H. A., Helvacıoğlu, D., Turan, S., Bereket, A., & Güran, T. (2026) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2026.2026-1-17
“…antibody (mAb) immunoassays, which offer higher analytical specificity, has led to the adoption of lower peak cortisol cut-off values, most commonly 18 μ g/dL (500 nmol/L), with subsequent studies suggesting even lower cut-offs, ranging from 12.6 to 15.7 μ g/dL (8,9,10,11,12,13,14,15,16).”
InfluentialSun, G. (2026) · Springer eBooks · doi:10.1007/978-3-031-90919-1_33-1
Risk factors for adrenal insufficiency after adrenalectomy for mild autonomous cortisol secretion
Aggarwal, A., Balkan, A. O., Sistla, D., Mastandrea, K., Dassanaike-Perera, M., Seethala, R. R., Leung, J. H., Yip, L., Ramonell, K. M., McCoy, K. L., et al. (2026) · Surgery · doi:10.1016/j.surg.2026.110307
Wan-Nik, F. H., Zulkeflee, H. A., Rahim, N. S. A., & Tuan-Ismail, S. T. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v15.i2.113666
Laboratory Evaluation of the Hypothalamic-Pituitary-Adrenal Axis
Greere, D., & Păun, D. L. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016109
Comps, O., Carrera, M.-J., Garcia, S., Moltó, L., & Montes, A. (2026) · European Journal of Anaesthesiology Intensive Care · doi:10.1097/ea9.0000000000000128
Liver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity
Park, S., Park, M., Yang, H. W., Park, J., Yu, S. J., Park, S. S., Choi, M. H., Cho, E. J., & Kim, J. H. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70149
Păun, D. L. (2026) · Directory of Open access Books (OAPEN Foundation)
Akkuş, D., Memisoglu, E., Huseynli, K., İbrahimli, A., Pérez-Soto, R. H., Rao, P., Correa, R., & Berber, E. (2026) · Surgery · doi:10.1016/j.surg.2026.110585
Kono, T., Hyakutake, S., Nishimura, M., Ishikawa, H., Koga, K., & Tanaka, T. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag267
“The conventional postcosyntropin cutoff of 18 µg/dL (SI: 497 nmol/L) derives from older assays; for the more specific LC-MS/MS used here, Javorsky et al [6] proposed lower cutoffs (14.5 µg/dL [SI: 400 nmol/L] at 30 minutes and 13.7 µg/dL [SI: 378 nmol/L] at 60 minutes).”
InfluentialSali, E., Paschou, I. A., Dimopoulou, S. M., Tagka, A., Chasapi, V., Nicolaidou, E., Stratigos, A. J., Peppa, Μ., & Paschou, S. Α. (2026) · Endocrine · doi:10.1007/s12020-026-04778-2
“Indicatively, older assays used a cut-off concentration of 18 µg/dL (500 nmol/L), while newer monoclonal antibody assays and LC-MS/MS have set the cut-off points around 14.5 µg/dL (400 nmol/L) [8, 42, 56].”
InfluentialCan Eosinophilia Serve as A Parameter for Adrenal Insufficiency?
Hashimoto, N. (2026) · OALib · doi:10.4236/oalib.1115956
Kageyama, K., Sato, K., Yamagata, S., Tasso, M., Nakada, Y., & Sawada, S. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73582
“The historical stimulated cortisol cutoff of 18 μg/dL was established using older cortisol assays, whereas lower assay-specific thresholds have been proposed for newer, more specific immunoassays [14].”
Cortisol Cutoffs for Adrenal Insufficiency Using Elecsys II: A Systematic Review
Haunton, S., Leppinen, N., MacDonald, H. R., Tobin, R., Rooman, R., Ward, L. M., Ahmet, A. H., & Dang, U. J. (2026) · Clinical Endocrinology · doi:10.1111/cen.70218
Metadata
- Authors
- Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W.
- Affiliations
- Froedtert Hospital (US)
- Medical College of Wisconsin (US)
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
- Mayo Clinic (US)
- Corresponding author
- Javorsky, Bradley R
- ORCID
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2021-02-18
- Volume
- 5
- Issue
- 4
- Pages
- bvab022-bvab022
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC7975762
- OpenAlex
- W3132722879
- Semantic Scholar
- d204c31770bedad774ffe4ea48c1fe1f03f7bedd
- Cited by
- 171
- References
- 39
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 37 · 2023: 32 · 2022: 24 · 2021: 11
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Advocate Aurora Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- adrenal insufficiency, ACTH stimulation test, monoclonal antibody assay, false positives, baseline cortisol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.